Skip to main content
. 2021 Jul 1;11:13670. doi: 10.1038/s41598-021-93203-x

Figure 2.

Figure 2

Right back scar at baseline (above) and at 6-month follow-up (below). The right half of the scar was treated with high-dose botulinum toxin type A (BTxA) and the left half was treated with low-dose BTxA.